advertisement
Schachar RA 1
Showing records 1 to 1 | Display all abstracts from Schachar RA46688 A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension
Schachar RA; Raber S; Courtney R; Zhang M
Current Eye Research 2011; 36: 809-817
